Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study

NCT01877668 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

422

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriatic Arthritis

Interventions

DRUG: Tofacitinib 5 mg BID
DRUG: Tofacitinib 10 mg BID
DRUG: Adalimumab
DRUG: Placebo
DRUG: Placebo

Sponsor

Pfizer